See All Slides -

Slides

Presentation TCT 2012

Case Selection for Alcohol Septal Ablation

Presenter: Sherif Nagueh

October 25, 2012

Presentation TCT 2012

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Presenter: C. Michael Gibson

October 25, 2012

Presentation TCT 2012

Coronary ISR: An Accepted Clinical Indication in the DES World?

Presenter: Huay Cheem Tan

October 25, 2012

Presentation TCT 2012

A Clinician's Perspectives

Presenter: David Kandzari

October 25, 2012

Presentation TCT 2012

Debate: Clopidogrel is Enough and Still Plays a Role for Most!

Presenter: Michael Love

October 25, 2012

Presentation TCT 2012

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Presenter: Juan Granada

October 25, 2012

Presentation TCT 2012

Step-by-Step Case: Percutaneous Closure of Mitral Paravalvular Leak: Retrograde Approach

Presenter: Eulogio Garcia

October 25, 2012

Presentation TCT 2012

Echocardiographic Diagnosis and Guidance of Aortic Paravalvular Leak Closure

Presenter: Vuyisile Nkomo

October 25, 2012

Presentation TCT 2012

LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents

Presenter: Patrick Serruys

October 25, 2012

Presentation TCT 2012

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Presenter: Dean Kereiakes

October 25, 2012

Advertisement

Slides

Case Selection for Alcohol Septal Ablation

Novel Anticoagulants in Patients with Acute Coronary Syndromes

Coronary ISR: An Accepted Clinical Indication in the DES World?

A Clinician's Perspectives

Debate: Clopidogrel is Enough and Still Plays a Role for Most!

Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity

Step-by-Step Case: Percutaneous Closure of Mitral Paravalvular Leak: Retrograde Approach

Echocardiographic Diagnosis and Guidance of Aortic Paravalvular Leak Closure

LEADERS 5-Year: A Prospective, Randomized Trial of Bioabsorbable Polymer-based Biolimus-Eluting vs. Sirolimus-Eluting Stents

When Is PCI Justified in Complex (Non-Left Main) Multivessel Disease with Current Drug-Eluting Stents?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content